Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$56.62 +1.1%	$65.95	$54.98 ▼ $109.50	$83.23B	0.62	18.00 million shs	25.52 million shs
EW Edwards Lifesciences	$82.75 -0.5%	$82.16	$72.30 ▼ $87.89	$47.97B	0.87	5.79 million shs	3.33 million shs
IDXX IDEXX Laboratories	$572.20 -1.2%	$585.67	$485.40 ▼ $769.98	$45.69B	1.58	555,867 shs	758,867 shs
STE STERIS	$214.02 -0.2%	$224.30	$195.14 ▼ $269.44	$21.03B	0.95	647,058 shs	557,782 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+0.04%	-2.13%	-10.39%	-27.84%	-46.27%
EW Edwards Lifesciences	+0.31%	+2.50%	+2.52%	+6.60%	+11.03%
IDXX IDEXX Laboratories	+2.89%	+4.62%	+0.31%	-10.00%	+22.28%
STE STERIS	+0.80%	+1.02%	-2.35%	-11.94%	-3.39%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$56.62 +1.1%	$65.95	$54.98 ▼ $109.50	$83.23B	0.62	18.00 million shs	25.52 million shs
EW Edwards Lifesciences	$82.75 -0.5%	$82.16	$72.30 ▼ $87.89	$47.97B	0.87	5.79 million shs	3.33 million shs
IDXX IDEXX Laboratories	$572.20 -1.2%	$585.67	$485.40 ▼ $769.98	$45.69B	1.58	555,867 shs	758,867 shs
STE STERIS	$214.02 -0.2%	$224.30	$195.14 ▼ $269.44	$21.03B	0.95	647,058 shs	557,782 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+0.04%	-2.13%	-10.39%	-27.84%	-46.27%
EW Edwards Lifesciences	+0.31%	+2.50%	+2.52%	+6.60%	+11.03%
IDXX IDEXX Laboratories	+2.89%	+4.62%	+0.31%	-10.00%	+22.28%
STE STERIS	+0.80%	+1.02%	-2.35%	-11.94%	-3.39%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	2.92	Moderate Buy	$93.91	65.87% Upside
EW Edwards Lifesciences	2.79	Moderate Buy	$95.65	15.60% Upside
IDXX IDEXX Laboratories	2.64	Moderate Buy	$751.00	31.32% Upside
STE STERIS	2.71	Moderate Buy	$275.20	28.58% Upside

Current Analyst Ratings Breakdown

Latest STE, BSX, EW, and IDXX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/29/2026	BSX Boston Scientific	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/28/2026	IDXX IDEXX Laboratories	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$730.00 ➝ $640.00
4/27/2026	IDXX IDEXX Laboratories	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C+)
4/27/2026	EW Edwards Lifesciences	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$104.00 ➝ $110.00
4/24/2026	EW Edwards Lifesciences	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Hold	$89.00 ➝ $90.00
4/24/2026	EW Edwards Lifesciences	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$93.00
4/24/2026	EW Edwards Lifesciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Hold	$87.00 ➝ $85.00
4/24/2026	EW Edwards Lifesciences	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$85.00 ➝ $87.00
4/24/2026	EW Edwards Lifesciences	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$98.00 ➝ $100.00
4/23/2026	BSX Boston Scientific	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$105.00 ➝ $100.00
4/23/2026	BSX Boston Scientific	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$90.00

(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$20.07B	4.19	$4.08 per share	13.87	$17.57 per share	3.22
EW Edwards Lifesciences	$6.07B	7.86	$2.85 per share	29.08	$17.81 per share	4.65
IDXX IDEXX Laboratories	$4.45B	10.22	$15.32 per share	37.32	$19.59 per share	29.19
STE STERIS	$5.46B	3.84	$14.33 per share	14.94	$67.33 per share	3.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$2.90B	$2.39	23.69	15.10	1.03	17.29%	19.17%	10.77%	7/22/2026 (Estimated)
EW Edwards Lifesciences	$1.07B	$1.88	44.01	24.70	2.08	17.39%	15.17%	11.68%	7/23/2026 (Estimated)
IDXX IDEXX Laboratories	$1.06B	$13.58	42.11	34.98	3.41	24.63%	70.87%	32.56%	N/A
STE STERIS	$614.64M	$7.17	29.85	19.39	N/A	12.15%	14.34%	9.58%	5/11/2026 (Estimated)

Latest STE, BSX, EW, and IDXX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/11/2026	Q4 2026	STE STERIS	$2.89	N/A	N/A	N/A	$1.59 billion	N/A
5/5/2026	Q1 2026	IDXX IDEXX Laboratories	$3.41	$3.47	+$0.06	$3.47	$1.12 billion	$1.14 billion
4/23/2026	Q1 2026	EW Edwards Lifesciences	$0.7280	$0.78	+$0.0520	$0.66	$1.60 billion	$1.65 billion
4/22/2026	Q1 2026	BSX Boston Scientific	$0.7930	$0.80	+$0.0070	$0.90	$5.19 billion	$5.20 billion
2/10/2026	Q4 2025	EW Edwards Lifesciences	$0.62	$0.58	-$0.04	$0.16	$1.54 billion	$1.57 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.52	1.18%	+8.99%	35.15%	20 Years

Latest STE, BSX, EW, and IDXX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2026	STE STERIS	quarterly	$0.63	1.18%	6/8/2026	6/8/2026	6/26/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.42	1.90	1.08
EW Edwards Lifesciences	0.06	3.72	3.09
IDXX IDEXX Laboratories	0.19	1.12	0.90
STE STERIS	0.26	2.48	1.75

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
EW Edwards Lifesciences	79.46%
IDXX IDEXX Laboratories	87.84%
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.34%
EW Edwards Lifesciences	0.31%
IDXX IDEXX Laboratories	0.79%
STE STERIS	1.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	59,000	1.49 billion	1.48 billion	Optionable
EW Edwards Lifesciences	16,000	576.54 million	574.76 million	Optionable
IDXX IDEXX Laboratories	11,000	79.43 million	78.80 million	Optionable
STE STERIS	17,787	98.07 million	97.03 million	Optionable

STE, BSX, EW, and IDXX Headlines

Recent News About These Companies

Steris Expands Board, Appoints bioMérieux CEO Pierre Boulud

1 hour ago | tipranks.com

STERIS Appoints Pierre Boulud to Board of Directors

4 hours ago | globenewswire.com

Premier Fund Managers Ltd Sells 63,616 Shares of STERIS plc $STE

May 7 at 8:18 AM | marketbeat.com

Swedbank AB Purchases 14,500 Shares of STERIS plc $STE

May 7 at 6:52 AM | marketbeat.com

STERIS plc (NYSE:STE) Declares $0.63 Quarterly Dividend

May 6 at 8:50 AM | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Reduces Stock Position in STERIS plc $STE

May 6 at 7:03 AM | marketbeat.com

Principal Financial Group Inc. Sells 93,864 Shares of STERIS plc $STE

May 6 at 6:15 AM | marketbeat.com

STERIS Announces Dividend of $0.63 per share

May 5 at 4:30 PM | globenewswire.com

STERIS (NYSE:STE) Sets New 12-Month Low - What's Next?

May 5 at 3:59 PM | marketbeat.com

STERIS (STE) Expected to Announce Earnings on Monday

May 4 at 1:17 PM | marketbeat.com

STERIS' Q4 Earnings on Deck: What's in Store for the Stock?

May 4 at 12:20 PM | zacks.com

Strs Ohio Acquires 25,204 Shares of STERIS plc $STE

May 4 at 6:37 AM | marketbeat.com

Danske Bank A S Sells 22,251 Shares of STERIS plc $STE

May 4 at 4:09 AM | marketbeat.com

UBS Group AG Acquires 125,521 Shares of STERIS plc $STE

May 2, 2026 | marketbeat.com

Mitsubishi UFJ Trust & Banking Corp Sells 13,075 Shares of STERIS plc $STE

May 2, 2026 | marketbeat.com

Vanguard Group Inc. Acquires 73,014 Shares of STERIS plc $STE

April 29, 2026 | marketbeat.com

Pictet Asset Management Holding SA Cuts Position in STERIS plc $STE

April 28, 2026 | marketbeat.com

Teacher Retirement System of Texas Acquires 11,070 Shares of STERIS plc $STE

April 27, 2026 | marketbeat.com

STERIS (NYSE:STE) Downgraded to Buy Rating by Wall Street Zen

April 26, 2026 | marketbeat.com

M&T Bank Corp Raises Stock Position in STERIS plc $STE

April 25, 2026 | marketbeat.com

Universal Beteiligungs und Servicegesellschaft mbH Grows Position in STERIS plc $STE

April 25, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

STE, BSX, EW, and IDXX Company Descriptions

Boston Scientific NYSE:BSX

$56.62 +0.62 (+1.11%)

Closing price 03:59 PM Eastern

Extended Trading

$56.33 -0.29 (-0.51%)

As of 07:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences NYSE:EW

$82.75 -0.45 (-0.54%)

Closing price 03:59 PM Eastern

Extended Trading

$82.80 +0.06 (+0.07%)

As of 06:56 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

IDEXX Laboratories NASDAQ:IDXX

$572.20 -7.03 (-1.21%)

Closing price 04:00 PM Eastern

Extended Trading

$572.00 -0.20 (-0.03%)

As of 06:00 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

STERIS NYSE:STE

$214.02 -0.44 (-0.20%)

Closing price 03:59 PM Eastern

Extended Trading

$213.74 -0.28 (-0.13%)

As of 07:42 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STE, BSX, EW, and IDXX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STE, BSX, EW, and IDXX Earnings

Compare Dividends

Latest STE, BSX, EW, and IDXX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STE, BSX, EW, and IDXX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

STE, BSX, EW, and IDXX Company Descriptions

Boston Scientific NYSE:BSX

Edwards Lifesciences NYSE:EW

IDEXX Laboratories NASDAQ:IDXX

STERIS NYSE:STE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools